Tito Serafini
Founder at ATRECA, INC.
Net worth: 27 736 $ as of 29/04/2024
Tito Serafini active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATRECA, INC. | Director/Board Member | 10/06/2010 | - |
| Founder | 10/06/2010 | - | |
| Chief Executive Officer | 10/06/2010 | 18/04/2018 | |
| Corporate Officer/Principal | 18/04/2018 | 30/01/2024 | |
| President | 10/06/2010 | 18/04/2018 | |
Anagenex, Inc.
 Anagenex, Inc. Packaged SoftwareTechnology Services Anagenex, Inc. is a company that uses high quality, large-scale data generation and AI to discover the next generation of small molecule medicines. Anagenex is based in San Francisco, CA. The company's platform leverages AI to design and synthesize hundreds of millions of target-specific compounds for testing in two weeks. The company's pipeline is focused on synthetic lethal oncology. The company was founded by Nicolas Tilmans and he has been the CEO since incorporation. | Director/Board Member | - | - |
Career history of Tito Serafini
Former positions of Tito Serafini
| Companies | Position | Start | End |
|---|---|---|---|
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Chief Tech/Sci/R&D Officer | 21/02/2010 | 31/12/2010 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Founder | 30/06/2000 | - |
| Corporate Officer/Principal | 30/06/2000 | - | |
| BROE CAPI | Director/Board Member | 27/01/2021 | - |
| Independent Dir/Board Member | 27/01/2021 | - | |
| University of California, Berkeley | Corporate Officer/Principal | - | - |
Training of Tito Serafini
| Case Western Reserve University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Founder | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ATRECA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Health Technology |
Brookline Capital Acquisition Corp.
 Brookline Capital Acquisition Corp. Financial ConglomeratesFinance Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on May 27, 2020 and is headquartered in New York, NY. | Finance |
Anagenex, Inc.
Anagenex, Inc. Packaged SoftwareTechnology Services Anagenex, Inc. is a company that uses high quality, large-scale data generation and AI to discover the next generation of small molecule medicines. Anagenex is based in San Francisco, CA. The company's platform leverages AI to design and synthesize hundreds of millions of target-specific compounds for testing in two weeks. The company's pipeline is focused on synthetic lethal oncology. The company was founded by Nicolas Tilmans and he has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Tito Serafini
- Experience
